19/12/2014 16:01:46 Free Membership Login

Merck News (NYSE:MRK)

DateTimeSource
Headline
12/19/20148:00AMBWMerck Begins Tender Offer to Acquire Cubist
Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist Pharmaceuticals, Inc. (NASDAQ:CBST). On Dec. 8, 2014, Merck announced its intent to acquire Cubist. Upon the successful closing of the... More...>>
12/18/20148:51AMDJNMerck Acquires OncoEthix for Up to $375 Million
By Angela Chen Merck & Co. acquired privately held OncoEthix for up to $375 million, its latest push into the oncology market as the pharmaceutical giant continues bolstering its research-and-development pipeline. OncoEthix is a Swiss-based biotechnology company specializing in oncology, or the study of cancer, one... More...>>
12/18/20147:30AMBWMerck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers
Acquisition Expands Merck’s Oncology Portfolio with Novel Oral BET Inhibitor, OTX015 Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has acquired, through a subsidiary, OncoEthix, a Swiss-based privately held biotechnology company specializing in oncology drug development... More...>>
12/12/20148:30PMPRNUSCUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over ...
CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc. - CBST Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors... More...>>
12/10/20149:30AMBWMerck Announces Appointment of Dr. Julie Gerberding as Executive Vice President for Strategic Communications, Global Public P...
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Dr. Julie Gerberding, 59, as executive vice president for strategic communications, global public policy and population health, effective Dec. 15. In this newly created Executive Committee position, Gerberding, who most... More...>>
12/10/20148:45AMBWInternational Breast Cancer Study Group, Breast International Group & Merck Announce Opening of International PANACEA Study o...
Collaborative Trial is First to Investigate an Anti-PD-1 Therapy, Pembrolizumab, Combined with Trastuzumab Study to Explore Whether New Approach May Reverse Trastuzumab Resistance in Cancer with Significant Unmet Need The International Breast Cancer Study Group (IBCSG), Breast International Group (BIG), and Merck, known... More...>>
12/10/20148:30AMBWData Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast ...
18.5 Percent Overall Response Rate Observed in KEYTRUDA-Treated Patients with This Aggressive Form of Breast Cancer Phase 2 Study Planned for the First Half of 2015 (KEYNOTE-086) Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today early study findings demonstrating an overall response... More...>>
12/09/20149:31PMPRNUSAcquisition of Cubist Pharmaceuticals, Inc. (CBST) by Merck & Co., Inc. (MRK) May Not Be in Shareholders' Best Interests
Acquisition of Cubist Pharmaceuticals, Inc. (CBST) by Merck & Co., Inc. (MRK) May Not Be in Shareholders' Best Interests PR Newswire SAN DIEGO and LEXINGTON, Mass., Dec. 9, 2014 SAN DIEGO and LEXINGTON, Mass., Dec. 9, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed... More...>>
12/09/20144:08PMDJNMerck Reaffirms Commitment to Cubist Deal Despite Patent Ruling -- Update
By Chelsey Dulaney Drug maker Merck & Co. is facing criticism that it is overpaying for its planned $8.4 billion purchase of antibiotics specialist Cubist Pharmaceuticals Inc., in light of a court ruling issued hours after the deal was announced Monday that could dampen the sales potential for Cubist's top-selling... More...>>
12/09/20143:54PMDJNMARKET SNAPSHOT: The S&P 500 Recorded Its Biggest Drop In Nearly 7 Weeks
By Anora Mahmudova and Sara Sjolin, MarketWatch Energy, materials stocks sell off NEW YORK (MarketWatch) -- U.S. stocks suffered their biggest one-day slide in nearly seven weeks on Monday as a withering selloff among energy companies, which closely tracked oil's continued price slide, dragged down key benchmark indexes... More...>>
12/09/20143:50PMDJNMerck Reaffirms Commitment to Cubist Deal Despite Patent Ruling
By Chelsey Dulaney Merck & Co. said its $8.4 billion acquisition of Cubist Pharmaceuticals Inc. will proceed as planned, even after a federal court ruled that the company's flagship antibiotic could be subject to generic competition in two years. Shares of Merck were off 3% in premarket trading, while Cubist was down... More...>>
12/09/20148:11AMBWMerck Statement Regarding CUBICIN Patent Litigation
Company Reaffirms Transaction To Proceed as Planned; Expected to Close in First Quarter of 2015 Merck, known as MSD outside the United States and Canada, issued the following statement regarding the decision of the U.S. District Court for the District of Delaware. The decision, which upheld the patent for CUBICIN that... More...>>
12/08/201410:16PMDJNMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update
By Peter Loftus and Dana Cimilluca Merck & Co. agreed to buy Cubist Pharmaceuticals Inc. for $8.4 billion as the drug giant pushes deeper into antibiotics, an area seeing renewed interest because of the rise of dangerous new infections. The deal, which also includes the assumption of $1.1 billion in debt, is worth... More...>>
12/08/20147:12PMDJNMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 5th Update
By Peter Loftus And Dana Cimilluca Merck & Co. agreed to buy Cubist Pharmaceuticals Inc. for $8.4 billion as the drug giant pushes deeper into antibiotics, an area seeing renewed interest because of the rise of dangerous new infections. The deal, which also includes the assumption of $1.1 billion in debt, is worth... More...>>
12/08/20147:11PMDJNMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 4th Update
By Peter Loftus And Dana Cimilluca Merck & Co. agreed to buy Cubist Pharmaceuticals Inc. for $8.4 billion as the drug giant pushes deeper into antibiotics, an area seeing renewed interest because of the rise of dangerous new infections. The deal, which also includes the assumption of $1.1 billion in debt, is worth... More...>>
12/08/20147:10PMDJNMARKET SNAPSHOT: The S&P 500 Recorded Its Biggest Drop In Nearly 7 Weeks
By Anora Mahmudova and Sara Sjolin, MarketWatch Energy, materials stocks sell off NEW YORK (MarketWatch) -- U.S. stocks suffered their biggest one-day slide in nearly seven weeks on Monday as a withering selloff among energy companies, which closely tracked oil's continued price slide, dragged down key benchmark indexes... More...>>
12/08/20147:07PMDJNMARKET SNAPSHOT: The S&P 500 Recorded Its Biggest Drop In Nearly 7 Weeks
By Anora Mahmudova and Sara Sjolin, MarketWatch Energy, materials stocks sell off NEW YORK (MarketWatch) -- U.S. stocks suffered their biggest one-day slide in nearly seven weeks on Monday as a withering selloff among energy companies, which closely tracked oil's continued price slide, dragged down key benchmark indexes... More...>>
12/08/20147:04PMDJNMARKET SNAPSHOT: Energy Companies Drag U.S. Stocks Lower
By Anora Mahmudova and Sara Sjolin, MarketWatch McDonald's skids after disappointing November sales figures NEW YORK (MarketWatch) -- U.S. stocks came off session lows but were still on track for the steepest declines in nearly seven weeks on Monday as a brutal selloff among energy companies, which closely tracked oil's... More...>>
12/08/20146:58PMDJNMARKET SNAPSHOT: Energy Companies Drag U.S. Stocks Lower
By Anora Mahmudova and Sara Sjolin, MarketWatch McDonald's skids after disappointing November sales figures NEW YORK (MarketWatch) -- The U.S. stock market moved lower on Monday as sharp falls among energy companies, which closely tracked oil's continued price slide, dragged down the key benchmarks. Downbeat economic reports... More...>>
12/08/20146:57PMDJNMARKET SNAPSHOT: Energy Companies Drag U.S. Stocks Lower
By Anora Mahmudova and Sara Sjolin, MarketWatch McDonald's skids after disappointing November sales figures NEW YORK (MarketWatch) -- The U.S. stock market moved lower on Monday as sharp falls among energy companies, which closely tracked oil's continued price slide, dragged the key benchmarks. Downbeat economic reports... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse mrk141219 16:01